# KCNJ18

## Overview
KCNJ18 is a gene that encodes the protein potassium inwardly rectifying channel subfamily J member 18, commonly referred to as Kir2.6. This protein is a member of the inwardly rectifying potassium channel family, which plays a critical role in maintaining the resting membrane potential and regulating cellular excitability in skeletal muscle cells. Kir2.6 is specifically expressed in skeletal muscle and is essential for normal muscle function by facilitating the flow of potassium ions into the cell. This ion flow is crucial for stabilizing the resting membrane potential and ensuring proper muscle contraction and relaxation. The activity of Kir2.6 is influenced by thyroid hormones, which can enhance its transcription, linking it to conditions such as thyrotoxic periodic paralysis when dysregulated (Soufi2018Increased; Cheng2011Identification). Variants in the KCNJ18 gene have been associated with various forms of periodic paralysis, highlighting its clinical significance in muscle physiology and pathology (Kuhn2015RareKCNJ18variants; Noso2019Contribution).

## Structure
The KCNJ18 gene encodes the Kir2.6 protein, which is part of the inwardly rectifying potassium channel family. These channels typically have a tetrameric quaternary structure, with each subunit containing two transmembrane helices and a pore-forming loop (Stowasser2017Potassium). The Kir2.6 protein is involved in maintaining muscle cell membrane excitability and is specifically expressed in skeletal muscle (Noso2019Contribution).

The molecular structure of Kir2.6 includes distinct domains: intracellular, transmembrane, and extracellular. Single-nucleotide variants (SNVs) identified in the KCNJ18 gene, such as R39Q, R40H, A56Q, and I249V, are located in the intracellular domain, while V100I is in the transmembrane domain, and G145S is in the extracellular domain (Noso2019Contribution). These domains suggest a complex structure that facilitates its function as a potassium channel.

Post-translational modifications, such as phosphorylation, can affect the activity of these channels, although specific modifications for Kir2.6 are not detailed in the provided context (Stowasser2017Potassium). The structural configuration of Kir2.6 is crucial for its role in ion flow regulation, which is essential for muscle function and excitability.

## Function
The KCNJ18 gene encodes the Kir2.6 protein, a skeletal muscle-specific inwardly rectifying potassium (K+) channel. This channel plays a crucial role in maintaining the resting membrane potential and regulating cellular excitability in skeletal muscle cells. Kir2.6 channels facilitate the flow of potassium ions into the cell, which is essential for stabilizing the resting membrane potential and ensuring proper muscle function (Cheng2011Identification). In healthy human cells, Kir2.6 is involved in maintaining normal muscle excitability and function by regulating potassium ion conductance across the cell membrane (Kuhn2015RareKCNJ18variants).

The proper function of Kir2.6 is vital for preventing pathological conditions such as hypokalemic periodic paralysis, which is characterized by episodes of muscle weakness and paralysis due to impaired potassium ion homeostasis (Cheng2011Identification). The channel's activity is influenced by thyroid hormones, which can enhance its transcription, indicating a role in muscle physiology and potential involvement in periodic paralysis when its expression is dysregulated (Soufi2018Increased). Kir2.6 channels are primarily active in the cell membrane, where they contribute to the regulation of muscle contraction and relaxation (Soufi2018Increased).

## Clinical Significance
Mutations and alterations in the KCNJ18 gene, which encodes the Kir2.6 potassium channel, have been implicated in several forms of periodic paralysis. A notable condition associated with KCNJ18 is thyrotoxic periodic paralysis (TPP), characterized by episodes of muscle weakness and hypokalemia, often linked to hyperthyroidism. Specific haplotypes of KCNJ18, such as A-A-A-G, have been associated with increased susceptibility to TPP, particularly in Asian populations, where these genetic variations are more prevalent (Noso2019Contribution).

In addition to TPP, mutations in KCNJ18 have been linked to sporadic normokalemic periodic paralysis. A gain-of-function variant in the promoter region of KCNJ18, specifically the c.-542T>A mutation, significantly increases transcription of the gene, leading to hyperpolarization of skeletal muscle membrane potentials and reduced muscle excitability. This can result in muscle weakness and paralysis under normokalemic conditions (Soufi2018Increased).

The pathogenicity of KCNJ18 variants in hypokalemic periodic paralysis (hypoKPP) has been debated, with some studies identifying mutations that reduce Kir2.6 channel function, contributing to muscle inexcitability during hypokalemic episodes (Cheng2011Identification). However, other research suggests that KCNJ18 alterations are rarely pathogenic in hypoKPP (Kuhn2015RareKCNJ18variants).


## References


[1. (Soufi2018Increased) Muhidien Soufi, Volker Ruppert, Susanne Rinné, Tobias Mueller, Bilgen Kurt, Guenter Pilz, Andreas Maieron, Richard Dodel, Niels Decher, and Juergen R. Schaefer. Increased kcnj18 promoter activity as a mechanism in atypical normokalemic periodic paralysis. Neurology Genetics, October 2018. URL: http://dx.doi.org/10.1212/nxg.0000000000000274, doi:10.1212/nxg.0000000000000274. This article has 6 citations.](https://doi.org/10.1212/nxg.0000000000000274)

[2. (Kuhn2015RareKCNJ18variants) Marius Kuhn, Karin Jurkat-Rott, and Frank Lehmann-Horn. Rarekcnj18variants do not explain hypokalaemic periodic paralysis in 263 unrelated patients: table 1. Journal of Neurology, Neurosurgery &amp; Psychiatry, pages jnnp-2014-309293, April 2015. URL: http://dx.doi.org/10.1136/jnnp-2014-309293, doi:10.1136/jnnp-2014-309293. This article has 3 citations.](https://doi.org/10.1136/jnnp-2014-309293)

[3. (Stowasser2017Potassium) Michael Stowasser. Potassium Channel Mutations and Human Disease, pages 503–516. Elsevier, 2017. URL: http://dx.doi.org/10.1016/B978-0-12-802168-2.00041-5, doi:10.1016/b978-0-12-802168-2.00041-5. This article has 0 citations.](https://doi.org/10.1016/B978-0-12-802168-2.00041-5)

[4. (Noso2019Contribution) Shinsuke Noso, Naru Babaya, Yoshihisa Hiromine, Hiroyuki Ito, Yasunori Taketomo, Sawa Yoshida, Fumimaru Niwano, Keisuke Monobe, Tatsuro Minohara, Takuya Okada, Mamiko Tsugawa, Yumiko Kawabata, and Hiroshi Ikegami. Contribution of asian haplotype of kcnj18 to susceptibility to and ethnic differences in thyrotoxic periodic paralysis. The Journal of Clinical Endocrinology &amp; Metabolism, 104(12):6338–6344, July 2019. URL: http://dx.doi.org/10.1210/jc.2019-00672, doi:10.1210/jc.2019-00672. This article has 5 citations.](https://doi.org/10.1210/jc.2019-00672)

[5. (Cheng2011Identification) Chih-Jen Cheng, Shih-Hua Lin, Yi-Fen Lo, Sung-Sen Yang, Yu-Juei Hsu, Stephen C. Cannon, and Chou-Long Huang. Identification and functional characterization of kir2.6 mutations associated with non-familial hypokalemic periodic paralysis. Journal of Biological Chemistry, 286(31):27425–27435, August 2011. URL: http://dx.doi.org/10.1074/jbc.m111.249656, doi:10.1074/jbc.m111.249656. This article has 47 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m111.249656)